Debioclinic - global biopharmaceutical development - in-licensing of promising biologics and small molecule drug candidates

Home

What is Debioclinic ?

- 15 years experience
- 80 phase I to III trials
- 20 countries covered
- More than 6,000 patients
- 32 team members

OUR TEAM

Debioclinic team members are highly experienced individuals with a strong committment to Debiopharm Group's objectives.

Currently, more than 32 persons are employed in Debioclinic, mainly operational staff. The organigram below shows our operational organisation for study conduct.

Short biographies will pop up in the organigram below.